House Committee Seeks Answers From FDA About Anticoagulant Adverse Events
(Coumadin/warfarin letter available. Document #28-150917-011X.)
The letter from Committee Chair Fred Upton, R., Mich., and ranking member Frank Pallone Jr., D., N.J., was prompted by the July joint publication of an article in the Washington Post and on the website ProPublica reporting that from...
To view the full article, register now.